Back
Denali Therapeutics Stock Price Chart
Sponsored
DNLI
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
47
DNLI
Denali Therapeutics
Last Price:
27.01
Seasonality Move:
18.4%
7 Day Trial
ALL ACCESS PASS
$
7
Follow Warren Buffett's big oil bet with this ETF
Discover all about it HERE.- The current trend is relatively stagnant and DNLI is experiencing slight selling pressure.
Denali Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.63 | Sell |
20-day SMA: | 26.94 | Sell |
50-day SMA: | 27.28 | Sell |
200-day SMA: | 21.72 | Buy |
8-day EMA: | 26.73 | Sell |
20-day EMA: | 27.05 | Sell |
50-day EMA: | 26.66 | Sell |
200-day EMA: | 23.64 | Buy |
Denali Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 43.08 | Sell |
Chaikin Money Flow: | -171845 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.24 - 28.5) | Sell |
Bollinger Bands (100): | (22 - 27.78) | Buy |
Denali Therapeutics Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 25.96 while DNLI 8-day simple moving average is 26.63, which is a Sell signal.
- The stock price of DNLI is 25.96 while Denali Therapeutics 20-day SMA is 26.94, which makes it a Sell.
- Denali Therapeutics 50-day simple moving average is 27.28 while DNLI share price is 25.96, making it a Sell technically.
- DNLI stock price is 25.96 and Denali Therapeutics 200-day simple moving average is 21.72, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
47
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Sell
The current Denali Therapeutics [DNLI] share price is $25.96. The Score for DNLI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
3.72B
Price in USD:
25.96
Share Volume:
552.69K
Denali Therapeutics 52-Week Range
52-Week High:
32.13
52-Week Low:
14.56
Sell
47
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 25.96 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 25.96 while DNLI 8-day exponential moving average is 26.73, which is a Sell signal.
- The stock price of DNLI is 25.96 while Denali Therapeutics 20-day EMA is 27.05, which makes it a Sell.
- Denali Therapeutics 50-day exponential moving average is 26.66 while DNLI share price is 25.96, making it a Sell technically.
- DNLI stock price is 25.96 and Denali Therapeutics 200-day simple moving average is 23.64, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.55 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is -0.26, suggesting Denali Therapeutics is a Sell
- Denali Therapeutics Relative Strength Index (RSI) is 43.08, which suggest Denali Therapeutics is oversold
- The Bollinger Bands (25) for Denali Therapeutics is (26.24 - 28.5), which suggest Denali Therapeutics is a Buy
- The Bollinger Bands (100) for Denali Therapeutics is (22 - 27.78), which suggest Denali Therapeutics is a Buy
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.